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Abstract
B19 parvovirus (PV) infection is ordinarily resolved with the production of specific antibodies that neutralize virus infectivity for 
erythroid host cells. Nevertheless persistent infection with B19 PV and pure red blood cell aplasia have been documented. A 27 
year-old male. i.v. drug abuser, HIV+ and HCV was diagnosed of pure red cell aplasia. Six months later we had serologic 
evidence of persistent parvovirus infection. Interferon therapy, started for HCV infection, showed a marked improvement of 
anaemia and anti parvovirus IgM became negative. It is discussed the possible role of interferon therapy in persistent parvovirus 
infection.
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